Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01926587
Title Oral Rigosertib in Combination With Azacitidine
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Onconova Therapeutics, Inc.
Age Groups: adult
Covered Countries USA | FRA

No variant requirements are available.